Kabra Drugs Ltd.

View in App
5.12 ▼0%

20 November 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kabradrugs.com
Market Cap 2.25 Cr.
Enterprise Value(EV) 3.85 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.04 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share -2.25 Trailing Twelve Months Ending 2023-09
Price to Book Value -2.28 Calculated using Price: 5.12
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.44 Cr. 4,388,600 Shares
FaceValue 10
About Kabra Drugs Ltd.
The company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.

Kabra Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Kabra Drugs Ltd. Performance

View details >>
1 Day
1 Week
1 Month
-9.54%
3 Month
+36.17%
6 Month
-5.19%
1 Year
-0.58%
2 Year
-8.73%
5 Year
+406.93%
10 Year
-49.90%

Kabra Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.55 1.05 5.02 -171.40 -144.20 -2,869.33
Return on Capital Employed (%) 3.52 5.81 7.49 -80.09 -19.67 -8.82 -27.33 -27.96 -52.60
Return on Assets (%) 0.79 0.31 1.67 -58.30 -10.36 -4.11 -12.78 -17.39 -47.15

Kabra Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 3 3 0 0 0 0 0 -1 -1
Non Curr. Liab. 3 2 1 0 0
Curr. Liab. 3 4 3 1 1 1 2 1 1 2
Minority Int.
Equity & Liab. 9 9 6 2 1 1 1 1 1 1
Non Curr. Assets 3 3 3 0 0 0 0 0 0 0
Curr. Assets 6 6 4 1 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 9 9 6 2 1 1 1 1 1 1

Kabra Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 8 10 8 2
Other Income 0 0 0 0 0 0 0
Total Income 8 10 8 2 0 0 0
Total Expenditure -8 -9 -7 -3 0 0 0 0 0 0
PBIDT 0 0 1 -1 0 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0
Taxation 0 0 0
Exceptional Items -1
PAT 0 0 0 -2 0 0 0 0 0 0
Adjusted EPS 0 0 0 -5 0 0 0 0 -1 -1

Kabra Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0 0 2 0 0
Cash Fr. Finan. 0 1 0 0 -1 0 0 0 0
Net Change 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Kabra Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kabra Drugs Ltd. Announcements

View details >>
Mon, 13 Nov 2023
Undertaking For Non-Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended 30Th September 2023.
Undertaking for Non-Applicability of Regulation 32 of SEBI (LODR) Regulations 2015 for the Quarter ended 30th September 2023
Mon, 13 Nov 2023
Unaudited Financial Result For Quarter Ending 30Th September 2023 Pursuant ToRegulation 33 Of The SEBI (LODR) Regulations 2015.
Unaudited Financial Result for Quarter ending 30th September 2023
Mon, 13 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 13Th November 2023 As PerRegulation 30 And 31A Of SEBI (Listing Obligations And Disclosure Requirements)Regulations 2015.
With reference to the above captioned subject we hereby informed you that the Board ofDirectors at their meeting held today i.e. Monday 13th November 2023 04:00 PM. concluded at4:30 PM at the registered office of the company have considered and approved the following:UNAUDITED FINANCIAL RESULTSThe Board of Director have considered and approved the Unaudited Financial Results forquarter ended on 30th September 2023. In this regard please find enclosed herewith theunaudited Financial Results along with Limited Review Report on Quarterly Financial Results ofthe Company pursuant to the Regulation 33 of SEBI (LODR) Regulations 2015.The copy of the said unaudited quarterly financial results along with copy of Limited ReviewReport by Statutory auditor of the company is enclosed herewith.

Kabra Drugs Ltd. Technical Scans

View details >>

No Scans Found

Kabra Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Kabra Drugs Ltd. FAQ's

What is Kabra Drugs share price?
Can I buy Kabra Drugs shares now?
What is the Market Cap of Kabra Drugs?
What is the 52 Week High and Low of Kabra Drugs?